Safety and Effect of SANGUINATEā„¢ Infusion in Patients at Risk of Delayed Cerebral Ischemia (DCI) Following Subarachnoid Hemorrhage (SAH)


Phase 2 Results N/A

Summary of Purpose

Safety and effect of SANGUINATE on patients DCI following SAH.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 14 June 2016.

1 Dec 2014 12 Nov 2014 1 Jul 2016 1 Jul 2016 1 Jun 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Masking: Open Label
  • Endpoint: Safety Study
  • Intervention: Single Group Assignment


  • Rajat Dhar, MD